Upper Extremity Dysfunction Post Radial Percutaneous Coronary Intervention
Primary Purpose
Upper Extremity Dysfunction
Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Trans-Radial Percutaneous Coronary Intervention (TR-PCI)
Sponsored by
About this trial
This is an interventional prevention trial for Upper Extremity Dysfunction focused on measuring Upper extremity dysfunction, Trans-Radial Percutaneous Coronary Interventions
Eligibility Criteria
Inclusion Criteria:
- Presenting for TR-PCI at the study centre.
- The radial artery can be palpated and Doppler ultrasound examination of the radial artery shows non-occlusive flow.
Exclusion Criteria:
- Currently enrolled in another study that clinically interferes with this study and that has not passed the primary endpoint.
- The clinical condition prohibits or hinders informed consent and/or baseline examinations. E.g. cardiogenic shock and cardiopulmonary resuscitation or subconscious and semiconscious state,.
- Co-morbid condition(s) that could limit the subject's ability to participate in the study or to comply with follow-up requirements, or impact the scientific integrity of the study, e.g. loss of voluntary motor control of the studied extremities.
Sites / Locations
- Albert Schweitzer HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Trans-Radial PCI
Arm Description
Outcomes
Primary Outcome Measures
A binary score of upper extremity dysfunction
A positive score is defined as the presence of at least a ≥1 point increase in the Levine-Katz (Boston) questionnaire; or at least 2 of the following decreased scores compared to baseline, 2 weeks after TR-PCI:
≥15% decrease in the DASH-outcome measure.
Increase in VAS pain score with regard to the upper extremity of ≥2 points
Absent signal of the radial artery using Doppler
10% decrease in goniometry of the upper extremity, with a minimum decrease of 10 degree Strength
60N decrease in palmar grip strength
12N decrease in pinch grip strength
15% decrease in isometric strength of the following manoeuvres:
Flexion and extension of the elbow and/or wrist
Sensibility loss of ≥1 filament of the hand using Semmes-Weinstein filaments according to WEST
1cm increase at volumetry of the hand, using the Figure of 8-method
1cm increase at volumetry of the forearm, measured circumferentially 8 cm distal of the medial epicondyle
Compartment syndrome
Secondary Outcome Measures
Successful arterial access
Successful arterial access of the target radial artery, defined as the ability to successfully advance a guiding catheter and position it in the coronary ostium.
Cross-over
Percentage of cross-over from radial to femoral access
Anomaly
Presence of branching anomaly (high radial artery take-off), tortuosity (none, mild, moderate or severe), stenosis (not encountered or percentage of stenosis encountered) and/or spasm (none, mild, moderate or severe) of the radial artery
Access route complications
Access route complications, dissection or perforation of radial, brachial or subclavian artery, as evidenced by angiography or computed tomography
Procedural success
Procedural success (defined as <30% residual stenosis at the end of the procedure)
Catheter performance
Overall catheter performance ranging from 0 (very bad) - 5 (very good)
Procedure time
Procedure time in minutes, from guide catheter insertion to withdrawal
Radiation
Radiation time and dose, in minutes and mGy
MACCE
Major adverse cardiac and cerebrovascular events (MACCE), defined as:
Myocardial infarction (MI), according to the Third Universal definition of Myocardial Infarction
Target vessel revascularisation, either by PCI or surgical
Death
Cerebrovascular accident (CVA)
Bleeding
Bleeding events (according to Academic Research Consortium definitions) at procedure and at each consecutive follow-up
DASH
"Disabilities of the Arm, Shoulder and Hand" (DASH) outcome measured at two weeks, one and six months
VAS
Visual Analogue Scale pain score (VAS) with regard to the upper extremity at one day, two weeks, one and six months.
Occlusion
Presence or absence of arterial pulse when evaluating the radial artery using Doppler ultrasound examination extremity at one day, two weeks, one and six months
AROM
Active Range Of Motion (AROM) goniometry values in degrees of the upper extremity at two weeks, one and six months.
Strength
o Strength in Newton at two weeks, one and six months:
Palmar grip strength
Pinch grip strength
Isometric strength of the following manoeuvres:
Flexion and extension of the elbow
Flexion and extension of the wrist
Sensibility
Sensibility of the hand using Semmes-Weinstein filaments according to WEST at two weeks, one and six months.
Volumetry of the hand
Volumetry of the hand in centimeters using the Figure of eight-method extremity at one day, two weeks, one and six months.
Volumetry of the forearm
Volumetry of the forearm in centimetres at one day, two weeks, one and six months.
Levine-Katz (Boston) questionnaire
Symptom-severity score and the functional-status score of the Levine-Katz (Boston) questionnaire at two weeks, one and six months
Full Information
NCT ID
NCT02204423
First Posted
June 16, 2014
Last Updated
July 29, 2014
Sponsor
Albert Schweitzer Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02204423
Brief Title
Upper Extremity Dysfunction Post Radial Percutaneous Coronary Intervention
Official Title
Upper Extremity Dysfunction Post Radial PCI: A Cohort Study Evaluating Upper Extremity Dysfunction After Percutaneous Coronary Intervention Using the Radial Artery as Access Route
Study Type
Interventional
2. Study Status
Record Verification Date
July 2014
Overall Recruitment Status
Unknown status
Study Start Date
February 2014 (undefined)
Primary Completion Date
May 2015 (Anticipated)
Study Completion Date
November 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Albert Schweitzer Hospital
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Trans-Radial Percutaneous Coronary Intervention (TR-PCI) is rapidly becoming the gold standard. This is especially the case in primary Percutaneous Coronary Interventions (PCI), where most benefits of the radial approach, such as reduced major bleeding and mortality, can be expected. However there is very limited research available looking at the consequences of trans-radial access for upper extremity function.
The main objective of this study is to provide insight in the morbidity with regards to the upper extremity surrounding the radial access route in percutaneous coronary interventions. Secondary objectives are to provide insight in the consequences for functional status, factors influencing and financial costs of this morbidity, to identify subject who might benefit from early referral and treatment of this morbidity and to generate hypotheses for further clinical research into this matter.
The investigators hypothesis is that approximately 20% of the population will experience upper extremity dysfunction after TR-PCI.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Upper Extremity Dysfunction
Keywords
Upper extremity dysfunction, Trans-Radial Percutaneous Coronary Interventions
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
500 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Trans-Radial PCI
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Trans-Radial Percutaneous Coronary Intervention (TR-PCI)
Other Intervention Name(s)
Dotter-Procedure
Primary Outcome Measure Information:
Title
A binary score of upper extremity dysfunction
Description
A positive score is defined as the presence of at least a ≥1 point increase in the Levine-Katz (Boston) questionnaire; or at least 2 of the following decreased scores compared to baseline, 2 weeks after TR-PCI:
≥15% decrease in the DASH-outcome measure.
Increase in VAS pain score with regard to the upper extremity of ≥2 points
Absent signal of the radial artery using Doppler
10% decrease in goniometry of the upper extremity, with a minimum decrease of 10 degree Strength
60N decrease in palmar grip strength
12N decrease in pinch grip strength
15% decrease in isometric strength of the following manoeuvres:
Flexion and extension of the elbow and/or wrist
Sensibility loss of ≥1 filament of the hand using Semmes-Weinstein filaments according to WEST
1cm increase at volumetry of the hand, using the Figure of 8-method
1cm increase at volumetry of the forearm, measured circumferentially 8 cm distal of the medial epicondyle
Compartment syndrome
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Successful arterial access
Description
Successful arterial access of the target radial artery, defined as the ability to successfully advance a guiding catheter and position it in the coronary ostium.
Time Frame
During procedure
Title
Cross-over
Description
Percentage of cross-over from radial to femoral access
Time Frame
During procedure
Title
Anomaly
Description
Presence of branching anomaly (high radial artery take-off), tortuosity (none, mild, moderate or severe), stenosis (not encountered or percentage of stenosis encountered) and/or spasm (none, mild, moderate or severe) of the radial artery
Time Frame
During procedure
Title
Access route complications
Description
Access route complications, dissection or perforation of radial, brachial or subclavian artery, as evidenced by angiography or computed tomography
Time Frame
6 months
Title
Procedural success
Description
Procedural success (defined as <30% residual stenosis at the end of the procedure)
Time Frame
During procedure
Title
Catheter performance
Description
Overall catheter performance ranging from 0 (very bad) - 5 (very good)
Time Frame
During procedure
Title
Procedure time
Description
Procedure time in minutes, from guide catheter insertion to withdrawal
Time Frame
During procedure
Title
Radiation
Description
Radiation time and dose, in minutes and mGy
Time Frame
During procedure
Title
MACCE
Description
Major adverse cardiac and cerebrovascular events (MACCE), defined as:
Myocardial infarction (MI), according to the Third Universal definition of Myocardial Infarction
Target vessel revascularisation, either by PCI or surgical
Death
Cerebrovascular accident (CVA)
Time Frame
6 months
Title
Bleeding
Description
Bleeding events (according to Academic Research Consortium definitions) at procedure and at each consecutive follow-up
Time Frame
6 months
Title
DASH
Description
"Disabilities of the Arm, Shoulder and Hand" (DASH) outcome measured at two weeks, one and six months
Time Frame
6 months
Title
VAS
Description
Visual Analogue Scale pain score (VAS) with regard to the upper extremity at one day, two weeks, one and six months.
Time Frame
6 months
Title
Occlusion
Description
Presence or absence of arterial pulse when evaluating the radial artery using Doppler ultrasound examination extremity at one day, two weeks, one and six months
Time Frame
6 months
Title
AROM
Description
Active Range Of Motion (AROM) goniometry values in degrees of the upper extremity at two weeks, one and six months.
Time Frame
6 months
Title
Strength
Description
o Strength in Newton at two weeks, one and six months:
Palmar grip strength
Pinch grip strength
Isometric strength of the following manoeuvres:
Flexion and extension of the elbow
Flexion and extension of the wrist
Time Frame
6 months
Title
Sensibility
Description
Sensibility of the hand using Semmes-Weinstein filaments according to WEST at two weeks, one and six months.
Time Frame
6 months
Title
Volumetry of the hand
Description
Volumetry of the hand in centimeters using the Figure of eight-method extremity at one day, two weeks, one and six months.
Time Frame
6 months
Title
Volumetry of the forearm
Description
Volumetry of the forearm in centimetres at one day, two weeks, one and six months.
Time Frame
6 months
Title
Levine-Katz (Boston) questionnaire
Description
Symptom-severity score and the functional-status score of the Levine-Katz (Boston) questionnaire at two weeks, one and six months
Time Frame
6 months
Other Pre-specified Outcome Measures:
Title
Hand centre
Description
o If the primary endpoint has been reached:
Diagnostic procedures performed at the hand centre
Diagnosis of the hand centre
Performed treatment at the hand centre
Upper extremity related absence of work in days
Time Frame
After reaching primary endpoint
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Presenting for TR-PCI at the study centre.
The radial artery can be palpated and Doppler ultrasound examination of the radial artery shows non-occlusive flow.
Exclusion Criteria:
Currently enrolled in another study that clinically interferes with this study and that has not passed the primary endpoint.
The clinical condition prohibits or hinders informed consent and/or baseline examinations. E.g. cardiogenic shock and cardiopulmonary resuscitation or subconscious and semiconscious state,.
Co-morbid condition(s) that could limit the subject's ability to participate in the study or to comply with follow-up requirements, or impact the scientific integrity of the study, e.g. loss of voluntary motor control of the studied extremities.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sander IJsselmuiden, MD, PHD
Phone
+31-78-6542039
Email
s.ijsselmuiden@asz.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Roos Koopman, MD
Phone
+31-78-6550594
Email
A.g.m.koopman@asz.nl
Facility Information:
Facility Name
Albert Schweitzer Hospital
City
Dordrecht
State/Province
Zuid-Holland
ZIP/Postal Code
3318 AT
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Roos Koopman, MD
Phone
+31-78-6550594
Email
a.g.m.koopman@asz.nl
First Name & Middle Initial & Last Name & Degree
Sander IJsselmuiden, MD, PHD
Phone
+31-78-6542039
Email
s.ijsselmuiden@asz.nl
First Name & Middle Initial & Last Name & Degree
Sander IJsselmuiden, MD, PHD
First Name & Middle Initial & Last Name & Degree
Carlo Holtzer, MD, PHD
First Name & Middle Initial & Last Name & Degree
Roos Koopman, MD
12. IPD Sharing Statement
Learn more about this trial
Upper Extremity Dysfunction Post Radial Percutaneous Coronary Intervention
We'll reach out to this number within 24 hrs